Table 5. Pneumococcal vaccination rates with 95%-confidence intervals within three years in patients with “high-risk” condition for pneumococcal disease.
| N cohort | N vaccinated | Vaccination rate within 3 years after index date (95%-CI) | |
|---|---|---|---|
| Overall | 106,436 | 6,564 | 6.2 (6.0–6.3) |
| Age in categories and sex | |||
| Women 2–15 years | 2,356 | 19 | 0.8 (0.5–1.3) |
| Women 16–59 years | 30,303 | 676 | 2.2 (2.1-.2.4) |
| Women 60+ years | 26,749 | 2609 | 9.8 (9.4–10.1) |
| Men 2–15 years | 2,426 | 35 | 1.4 (1.0–2.0) |
| Men 16–59 years | 19,614 | 632 | 3.2 (3.0–3.5) |
| Men 60+ years | 24,988 | 2,593 | 10.4 (10.0–10.8) |
| “High-risk” condition at the index date | |||
| Malignant neoplasms excl. non-melanoma skin cancer | 28,187 | 1,908 | 6.8 (6.5–7.1) |
| HIV infection | 333 | 43 | 12.9 (9.5–17.0) |
| Chronic renal failure | 22,763 | 1,767 | 7.8 (7.4–8.1) |
| Immunosuppressant use with RA | 1,016 | 125 | 12.3 (10.4–14.5) |
| Immunosuppressant use without RA | 1,906 | 182 | 9.6 (8.3–11.0) |
| Region | |||
| Old Federal States / Western Germany | 98,502 | 5,891 | 6.0 (5.8–6.1) |
| New Federal States / Eastern Germany | 6,343 | 576 | 9.1 (8.4–9.8) |
CI = Confidence interval, RA = Rheumatoid arthritis